Converge Bio Secures $25M Funding Led by Bessemer & Tech Executives
AI Revolutionizes Drug Discovery: Converge Bio Secures $25 Million Funding Artificial intelligence (AI) is rapidly reshaping the landscape of drug discovery as pharmaceutical and biotech firms seek to accelerate research and development timelines along with increasing the success rate in a challenging economic environment. Over 200 startups are now vying to integrate AI into their … Read more
